Fakultni Nemocnice Kralovske Vinohrady

At Fakultni Nemocnice Kralovske Vinohrady, research in cardiovascular diseases centers on conditions such as acute myocardial infarction, atrial fibrillation, heart failure, and stroke prevention. These studies are mainly designed to test new ways to reduce clot-related events, improve recovery after heart attacks, and evaluate safer approaches to anticoagulation and bleeding control.

• Acute coronary syndrome, ST segment elevation myocardial infarction, and acute myocardial infarction
• Atrial fibrillation and prevention of stroke or systemic embolism
• Heart failure with pulmonary hypertension and primary prevention of atherosclerotic cardiovascular disease
• Testing new therapies to improve cardiovascular outcomes and reduce bleeding risk

The site’s Department of Cardiology 3FM CU and UHKV is especially active in studies that aim to improve everyday heart and stroke care for patients at higher risk.

Clinical research in neoplasms covers both solid tumors and blood cancers, including breast cancer, prostate cancer, endometrial cancer, melanoma, and several types of lymphoma and multiple myeloma. The trials are focused on evaluating new cancer treatments, improving disease control after surgery or transplant, and extending progression-free or recurrence-free survival.

• Advanced breast cancer, endometrial cancer, and high-risk prostate cancer
• Diffuse large B-cell lymphoma, follicular lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia
• Multiple myeloma and melanoma after complete resection
• Evaluating new immunotherapies and treatment combinations for better cancer control

These studies reflect a broad oncology portfolio at the Prague site, with attention to both newly diagnosed and relapsed disease.

Trials in skin and connective tissue diseases and immune system diseases focus on plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. The main goal is to assess newer treatments that may better control inflammation, relieve symptoms, and support longer-term safety in adults, adolescents, and children.

• Plaque psoriasis and moderate to severe atopic dermatitis
• Hidradenitis suppurativa in patients needing better symptom control
• Testing novel anti-inflammatory therapies for safety, tolerability, and effectiveness

This area shows strong interest in chronic inflammatory skin conditions, where improved quality of life is often a major research focus.

Research in eye diseases includes studies on geographic atrophy, macular edema, ocular hypertension, and open-angle glaucoma. These trials aim to improve vision-related outcomes, slow disease progression, and evaluate better ways to manage chronic eye conditions.

• Geographic atrophy linked to age-related macular degeneration
• Macular edema secondary to retinal vein occlusion
• Open-angle glaucoma and ocular hypertension
• Assessing treatments that may preserve vision and improve eye pressure control

These studies highlight the site’s role in testing therapies for both sight-threatening degeneration and pressure-related eye disease.

Trials in nutritional and metabolic diseases include obesity, overweight, and type 1 diabetes mellitus. The research is aimed at helping younger patients and adults through better weight management strategies and approaches that may preserve natural insulin production in newly diagnosed diabetes.

• Obesity and overweight in adolescents
• Type 1 diabetes mellitus in children, adolescents, and young adults
• Evaluating treatments that support weight reduction and metabolic health
• Testing therapies intended to maintain insulin secretion early in diabetes

These studies address common long-term metabolic conditions where early intervention can make a meaningful difference for patients.

Within nervous system diseases, the site is involved in studies of acute ischemic stroke, prevention after transient ischemic attack, and multiple sclerosis. The purpose of this research is to improve stroke prevention, support safer treatment choices, and explore longer-term control of inflammatory neurological disease.

• Acute ischemic stroke and prevention after high-risk transient ischemic attack
• Relapsing multiple sclerosis and progressive multiple sclerosis
• Evaluating new options to reduce recurrent stroke risk
• Studying long-term safety and tolerability in chronic neurological disease

These trials show a clear interest in both urgent vascular neurology and long-term neuroimmunology.

Research in bacterial infections and mycoses and respiratory tract diseases includes studies of severe community-acquired pneumonia. The main aim is to evaluate whether new treatments can improve survival and clinical recovery in hospitalized patients with serious infection.

• Severe community-acquired pneumonia
• Testing therapies designed to improve outcomes in serious hospital-treated infection
• Exploring better support for patients with acute respiratory illness

Although fewer in number than the cardiovascular and oncology programs, these trials address high-risk conditions where timely treatment is critical.

Additional studies at Fakultni Nemocnice Kralovske Vinohrady span a range of focused conditions, including IgA nephropathy, endometriosis-related pain, and pathological conditions, signs and symptoms that require targeted care. This mix reflects a research environment that supports both chronic inflammatory disease and symptom-focused treatment improvement.

• IgA nephropathy and kidney-related proteinuria
• Endometriosis and associated pelvic pain
• Assessing new therapies to reduce symptoms and slow disease activity

These studies add further breadth to the site’s portfolio, extending beyond the major cardiovascular and oncology programs.